CTRP9 Activators would describe a category of compounds that selectively target and enhance the biological activity of CTRP9, which stands for C1q/TNF-related protein 9. CTRP9 is a member of the CTRP family, proteins that are structurally related to adiponectin and are known to have a variety of roles in cellular metabolism and function. The protein is characterized by a C-terminal globular domain that is similar to that of adiponectin and is believed to be involved in its functional interaction with other cellular components. As an activator, these compounds would likely bind to CTRP9 and increase its biological activity, potentially influencing the protein's ability to interact with its targets. The search for CTRP9 Activators would typically include the use of in vitro assays designed to measure the interaction between CTRP9 and its binding partners or downstream signaling activities that are indicative of its functional engagement.
Upon discovery, CTRP9 Activators would undergo a thorough investigation to elucidate their mechanism of action at the molecular level. This might involve studies focusing on the binding affinity of these activators to the CTRP9 protein, using techniques such as surface plasmon resonance (SPR) or isothermal titration calorimetry (ITC) to characterize the interaction. Additionally, structural analyses could be performed using X-ray crystallography or cryo-electron microscopy (cryo-EM) to determine the activators' binding sites and to visualize how they induce conformational changes that enhance CTRP9's activity. In parallel, cellular assays would be used to monitor the response of cells to CTRP9 activation, which may involve changes in second messenger levels, alterations in gene expression profiles, or modifications in the metabolic activity of the cells. Such detailed characterization would not only advance the fundamental understanding of CTRP9's role in cellular physiology but also contribute to the broader knowledge of the CTRP family and its interactions within the cellular environment. Insight into the modulation of CTRP9 by activators could provide a deeper appreciation for the complex network of signals that govern metabolic processes and the maintenance of cellular homeostasis.
Items 11 to 11 of 11 total
Display:
Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
Troglitazone | 97322-87-7 | sc-200904 sc-200904B sc-200904A | 5 mg 10 mg 25 mg | $108.00 $200.00 $426.00 | 9 | |
A PPAR-γ agonist that could potentially induce CTRP9 expression, similar to other thiazolidinediones. |